Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Amway Herbal Drink
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Skin Laxity
1 trial -
AntiPlatelet therapy
The First People's Hospital of Lianyungang
Coronary Artery Disease
1 trial -
Apolipoprotein (ApoE) detection
Grace Therapeutics
Senile Plaques
1 trial -
Arcofolinยฎ 5-Methyltetrahydrofolate
United Therapeutics Europe Ltd
Pre-Eclampsia
1 trial -
Aspirin
Cardiff Oncology
Platelet Dysfunction Due to Aspirin
1 trial -
Atorvastatin 20 Mg Oral Tablet
The First People's Hospital of Lianyungang
Atherosclerotic Cardiovascular Disease
1 trial -
Avatrombopag 20 MG Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aplastic Anemia
1 trial -
BXD treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
IBD - Inflammatory Bowel Disease
1 trial -
Biobanking with genetic analysis
Chongqing Precision Biotech Co., Ltd
Chronic Inflammatory Disease
1 trial -
Blood draw for Lp(a)
Novartis Pharmaceuticals
Cardiovascular Disease and Lipoprotein(a)
1 trial -
Bright Changyou probiotic flavored yogurt
BRIGHT MINDS BIOSCIENCES INC.
Intestinal Health
1 trial -
Bupivacain
Hospital Authority, Hong Kong
Arthroplasty, Replacement, Knee
1 trial -
Bupropion
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Buyang Huanwu Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Glaucoma
1 trial -
CAR-T cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Philadelphia Positive Acute Lymphoblastic Leukemia
1 trial -
CCTA, CT-MPI, DSA, FFR
The First People's Hospital of Lianyungang
Coronary Microvascular Disease
1 trial -
CD19 CAR T-cell
Universal Integrated
B-cell Acute Lymphoblastic Leukemia
1 trial -
COVID Convalescent Plasma
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
CSB drum dried + ฮฑ-amylase
United Therapeutics Europe Ltd
Malnutrition
1 trial -
CT0590 CAR T Cells
The First People's Hospital of Lianyungang
Relapsed and/or Refractory Multiple Myeloma
1 trial -
Calcium Carbonate 1500 Mg with Vitamin D
Hospital Authority, Hong Kong
Thyroid Neoplasm
1 trial -
Cambridge Weight Plan
United Therapeutics Europe Ltd
Diabetes
1 trial -
Carrelizumab
The First People's Hospital of Lianyungang
Cholangiocarcinoma
1 trial -
Celastrol
Nanjing Legend Biotech Co.
Safety
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources